When does an app need FDA’s blessing?
Some apps help people look up symptoms, check drug side effects or locate. Some even measure blood pressure and blood sugar and send the readings off to the doctor. As a result, the Food and Drug Administration has concluded that at least some apps should undergo review by the agency before being permitted on the market. Dr. Jeffrey Shuren, who heads the FDA's Center for Devices and Radiological Health, stresses that the FDA has no plans to review most apps, such as those that help with wellness, healthier lifestyles. Same goes for those used to help patients manage their medical conditions. "The risk to patients are very, very low," he says.
- Surgical Checklists Unused in 10% of Hospitals, CMS Data Shows
- As Medicare Advantage Cuts Loom, Disagreement Over Program's Stability
- Doctors Feel Pressure to Accept Risk-based Reimbursement
- 3 Insider Tips on Cutting Costs without Strangling Growth
- 4 Tectonic Shifts Shaking Up Healthcare
- A Fresh Look at End-of-Life Care
- Heart Attack Patient Costs Skyrocket Beyond 30 Days
- 3 in 4 Patients Want E-mail Consultations
- ACGME Chief Sees 'Huge' Risk of Error in Proposed Assistant Physician Licensure
- Roundtable: To Arrest HAIs, Culture Trumps Campaigns